GEMS

Genius Group Launches Genius Metaversity 2.0 in Partnership with Vatom Labs and GeniusX

Retrieved on: 
Thursday, September 7, 2023
Learning, GEMS, Partnership, Meta, Education, 3D, Calendar, Campus, Mentorship, VR, Student, Faculty, Architecture, NYSE, AR, Tutoring, Tourism, Sales, Video game, Metaverse

SINGAPORE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, has launched Genius Metaversity 2.0, a virtual reality learning environment in partnership with GeniusX and Vatom Labs to hold educational courses and summits in the Metaverse.

Key Points: 
  • SINGAPORE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, has launched Genius Metaversity 2.0, a virtual reality learning environment in partnership with GeniusX and Vatom Labs to hold educational courses and summits in the Metaverse.
  • Genius Group’s Global AI Entrepreneur Summit held on September 6 and 7, 2023 is being hosted this week in Genius Metaversity 2.0 with over 6,000 entrepreneurs registered to attend.
  • Genius Metaversity has partnered with Vatom, who has provided the virtual environment and 3D platform together with virtual world-building tools in both Genius Metaversity 1.0 and 2.0, and with GeniusX, who is providing the architecture and design of the campuses, partner portal and global classrooms in Genius Metaversity 2.0.
  • Roger Hamilton, founder of Genius Group says: "We are excited to build on our partnership with Vatom Labs and to welcome GeniusX who are bringing their innovative designs to our Metaversity.

Epic Bio Named a “Fierce 15” Company by Fierce Biotech

Retrieved on: 
Monday, August 28, 2023
Technology, Research, Genetics, Clinical Trials, Health Technology, Biotechnology, Health, Science, Artificial Intelligence, GEMS, CRISPR, Face, Bio, Health care, DCAS, Clinical trial, Gene expression, FSHD, AAV, Creativity, Organization, Facioscapulohumeral muscular dystrophy, Engineering, Mouse, Muscular dystrophy, Cas, SOLVE, Pharmaceutical industry, Vaccine

Epic Bio , a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, has been named to Fierce Biotech’s 2023 “Fierce 15” list, designating it as one of the most outstanding early-stage biotechnology companies in the industry.

Key Points: 
  • Epic Bio , a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, has been named to Fierce Biotech’s 2023 “Fierce 15” list, designating it as one of the most outstanding early-stage biotechnology companies in the industry.
  • “We are very proud to be recognized by Fierce with this honor.
  • It’s a testament to the power of our epigenetic editing platform and the acumen of our team that we’ve made such exciting progress over the past year,” said Amber Salzman, Ph.D., chief executive officer of Epic Bio.
  • “For the past 21 years, we have assessed hundreds of early-stage companies for inclusion in the 'Fierce 15' special report.

Ball Aerospace's Pollution Monitoring Instrument Achieves First Light

Retrieved on: 
Thursday, August 24, 2023
GEMS, Environmental Research, Atmosphere, Maxar Technologies, TEMPO, Intelsat, Intelligence, Ball Aerospace & Technologies, Sulfur dioxide, Harvard University, Movement, Science, Formaldehyde, Pollutant, Harvard–Smithsonian Center for Astrophysics, Langley Research Center, Troposphere, Nitrogen dioxide, NASA, Cape Canaveral Space Force Station, Ozone, Weather, Principal, Communications satellite

BROOMFIELD, Colo., Aug. 24, 2023 /PRNewswire/ -- Ball Aerospace is celebrating alongside its mission partners today as the Tropospheric Emissions: Monitoring of Pollution (TEMPO) instrument releases its first images of Earth, the next step in its mission to improve air quality monitoring across greater North America.

Key Points: 
  • BROOMFIELD, Colo., Aug. 24, 2023 /PRNewswire/ -- Ball Aerospace is celebrating alongside its mission partners today as the Tropospheric Emissions: Monitoring of Pollution (TEMPO) instrument releases its first images of Earth, the next step in its mission to improve air quality monitoring across greater North America.
  • Following a monthslong commissioning process, the Ball-built instrument opened its aperture for the first time to perform solar calibration and make its inaugural scan across the continent.
  • TEMPO was developed alongside the Geostationary Environment Monitoring Spectrometer (GEMS), another Ball Aerospace-built instrument that launched in 2020 as part of an air quality monitoring mission for the South Korean National Institute of Environmental Research.
  • Go Beyond with Ball.® For more information, visit www.ball.com/aerospace or connect with us on Facebook or Twitter .

GEMS Girls' Clubs Celebrates International Day of the Girl, Oct 11

Retrieved on: 
Tuesday, August 22, 2023
Boys & Girls Club, GEMS, International Day of the Girl Child, International, Face, GEMS Girls' Clubs, Truth, The Truth Is..., Mentorship, Girl, Social media, Toy

GRAND RAPIDS, Mich., Aug. 22, 2023 /PRNewswire/ -- GEMS Girls' Clubs, a global ministry dedicated to growing girls in their faith for over 65 years, is excited to announce its International Day of the Girl celebration on October 11, 2023. The event coincides with the grand opening and ribbon cutting ceremony for the organization's new headquarters, along with a worldwide social media campaign that inspires and encourages girls by affirming the Truth of who God says they are.

Key Points: 
  • "At GEMS, our mission to support girls around the world is not confined to a single day—it is our lifelong commitment," says Cindy Bultema, Executive Director of GEMS.
  • "On this International Day of the Girl and every day, we want girls to know that they belong and they are loved by God," says Bultema.
  • The International Day of the Girl is a globally recognized day to celebrate and lift up girls while raising awareness about the challenges they face.
  • GEMS Girls Clubs invites everyone to participate and celebrate the International Day of the Girl in the following ways:
    Download and print the free GEMS' "The Truth Is" photo cards & share pictures on social media using the hashtags #GEMS #DayoftheGirl #ShareTheLOVED.

Genesis Therapeutics Closes Oversubscribed $200 Million Series B

Retrieved on: 
Monday, August 21, 2023
Biotechnology, Technology, Health, Pharmaceutical, Health Technology, Other Science, Research, Software, Artificial Intelligence, Science, Clinical Trials, GEMS, SAFE, Stanford University, Deep learning, BlackRock, Genentech, Eli Lilly, Patient, Structural biology, ADMET, Menlo Ventures, Artificial intelligence, Therapy, Computer science, Genesis, Pharmaceutical industry, Medical device, Chemistry, Series

Genesis Therapeutics , a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.

Key Points: 
  • Genesis Therapeutics , a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.
  • Additionally, the Series B capital will enable Genesis to ambitiously expand its pipeline, initiating new programs for underserved patient populations and leveraging the GEMS platform to make progress against challenging and previously undruggable targets.
  • This funding brings the total capital raised by Genesis Therapeutics to over $280 million.
  • In addition to the $200 million Series B raise, Genesis further announced that approximately $24 million of SAFE notes from a prior financing round, led by Radical Ventures, converted alongside the close of the Series B. Genesis previously raised a $52 million Series A , led by Rock Springs Capital, and a seed round of $4 million, led by a16z Bio + Health.

Epic Bio Presents New Data on Epigenetic Editing Platform at CRISPR Frontiers Conference

Retrieved on: 
Thursday, August 17, 2023
Science, Biotechnology, Research, Health, Artificial Intelligence, Health Technology, Technology, Genetics, GEMS, CRISPR, Bio, DCAS, Gene expression, Dicarboxylic acid, AAV, Machine learning, Protein engineering, Cas, Cold Spring Harbor, New York, Vaccine, Cold

Epic Bio , a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today presented new data on its epigenetic editing platform at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers conference, being held August 16-20, 2023, in Cold Spring Harbor, NY.

Key Points: 
  • Epic Bio , a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today presented new data on its epigenetic editing platform at Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers conference, being held August 16-20, 2023, in Cold Spring Harbor, NY.
  • Epic’s six poster presentations detail a variety of discoveries that expand upon the capabilities of the company’s powerful Gene Expression Modulation System (GEMS) platform.
  • Epic generated novel Cas effectors even smaller than CasMINI, under 500 amino acids in size, and with improved epigenetic editing activity.
  • The presentations will be made available under the publications section of the Science page on the Epic Bio website.

Morpheus Labs Joins Forces with Tencent Cloud to Drive Web3 Gaming and Metaverse Innovation in Asia-Pacific Region

Retrieved on: 
Wednesday, July 19, 2023
Cloud, GEMS, Blockchain, Partnership, Memorandum of understanding, Tencent, Esports, Growth, Ecosystem, Environment, Cryptocurrency, Video game, Web3

SINGAPORE, July 19, 2023 (GLOBE NEWSWIRE) -- Morpheus Labs, a leading provider of blockchain low code development platforms has announced that it has entered into a Memorandum of Understanding (MoU) with Tencent Cloud, the cloud business of global technology company Tencent, to cooperate on efforts to drive Web3 gaming and metaverse innovation, and promote the development of the Web3 ecosystem.

Key Points: 
  • SINGAPORE, July 19, 2023 (GLOBE NEWSWIRE) -- Morpheus Labs, a leading provider of blockchain low code development platforms has announced that it has entered into a Memorandum of Understanding (MoU) with Tencent Cloud, the cloud business of global technology company Tencent, to cooperate on efforts to drive Web3 gaming and metaverse innovation, and promote the development of the Web3 ecosystem.
  • The MoU will cover collaborations surrounding the development of digital technologies, blockchain, and Web3-related solutions.
  • The partnership will provide both Morpheus Labs and Tencent Cloud with the opportunity to grow their customer base and tap into each other's existing resources and solution models.
  • With this MoU, the gaming industry certainly looks to gain from the Morpheus Labs and Tencent Cloud partnership.

Fantasyland Hotel Partners with INTELITY for Mobile Guest Experience

Retrieved on: 
Thursday, July 13, 2023
GEMS, Partnership, Bed, ASSA, LOS, Transport, Online shopping, Hotel, Tourism, West Edmonton Mall, Victoria Coach Station

LOS ANGELES,  July 13, 2023 /PRNewswire-PRWeb/ -- INTELITY®, provider of hospitality's leading guest experience and staff management platform, has announced today a new partnership with Fantasyland Hotel in Edmonton, Alberta. The fun-seeking hotel has deployed INTELITY's mobile offerings providing guests with mobile check-in, mobile check-out, and mobile key, while streamlining the day-to-day operations for staff through GEMS® — INTELITY's suite of staff-facing tools.

Key Points: 
  • The exceptionally unique, experience-forward property puts guest convenience first with mobile check-in, mobile key and more
    LOS ANGELES, July 13, 2023 /PRNewswire-PRWeb/ -- INTELITY®, provider of hospitality's leading guest experience and staff management platform, has announced today a new partnership with Fantasyland Hotel in Edmonton, Alberta.
  • The fun-seeking hotel has deployed INTELITY's mobile offerings providing guests with mobile check-in, mobile check-out, and mobile key, while streamlining the day-to-day operations for staff through GEMS® — INTELITY's suite of staff-facing tools.
  • "At Fantasyland Hotel, our goal is to create a fun guest experience for more than just the weekend," said Jay Vashi, Director of Operations at Fantasyland Hotel.
  • "We are excited to welcome Fantasyland Hotel to the INTELITY family of properties," said Robert Stevenson, CEO of INTELITY.

The Hazelton Hotel Transforms the Guest Experience with INTELITY

Retrieved on: 
Wednesday, June 28, 2023
GEMS, Partnership, Culture, The Leading Hotels of the World, Concierge, Temperature, Tablet, HITEC, Collection, Les Clefs, AI, Forbes Travel Guide, Hotel, Tourism

TORONTO, June 28, 2023 /PRNewswire-PRWeb/ -- INTELITY®, provider of hospitality's leading guest experience and staff management platform, has announced a new partnership with The Hazelton Hotel in Toronto. The luxury boutique hotel has implemented the INTELITY platform to offer its guests a digital and modern, smart-room experience, as well as leverage INTELITY's GEMS® staff-facing tools to streamline its back-of-house operations.

Key Points: 
  • TORONTO, June 28, 2023 /PRNewswire-PRWeb/ -- INTELITY®, provider of hospitality's leading guest experience and staff management platform, has announced a new partnership with The Hazelton Hotel in Toronto.
  • The Hazelton Hotel property is part of The Leading Hotels of the World, the first and only Forbes Five-Star boutique hotel in Canada and the number one hotel on Tripadvisor (Traveler's Choice) in Toronto for seven consecutive years.
  • "We are committed to providing exceptional services to our guests which includes offering an enhanced digital experience through INTELITY," said Gaurav Dutta, The Hazelton Hotel's General Manager.
  • To experience the INTELITY platform and learn more about the Hazelton Hotel partnership at HITEC Toronto 2023 firsthand, visit booth #2106.

Epic Bio Presents Compelling Preclinical Data Supporting Clinical Initiation of EPI-321 for FSHD

Retrieved on: 
Friday, June 16, 2023
GEMS, Therapy, Biotechnology, DCAS, Clinical trial, Pharmacokinetics, CTA, Gene expression, FSHD, Messenger, Facioscapulohumeral muscular dystrophy, Patient, SAN, Hepatotoxicity, Poster, NHP, IND, Safety, Pharmaceutical industry, Science

SOUTH SAN FRANCISCO, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today presented new non-human primate (NHP) data supporting the clinical advancement of EPI-321 for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The data were presented in a poster at the FSHD International Research Congress being held June 15-16, 2023, in Milan, Italy.

Key Points: 
  • The data were presented in a poster at the FSHD International Research Congress being held June 15-16, 2023, in Milan, Italy.
  • “We are very encouraged by the totality of preclinical data on EPI-321, indicating this therapy can reverse disease pathophysiology in FSHD with a high degree of safety.
  • These results were made possible via Epic Bio’s unparalleled Gene Expression Modulation System (GEMS) platform, which overcomes limitations of other types of genetic medicines,” said Amber Salzman, Ph.D., chief executive officer of Epic Bio.
  • The presentation will be made available under the publications section of the Science page on the Epic Bio website.